Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hajj meningococcal carriage vaccine comparison trial
ACTRN12616001230448Phase 4Completed
- Sponsor
- National Centre for Immunisation Research and Surveillance
- Start
- Apr 2016
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 3
01
Overview
Phase 4, randomised, single-blind trial of meningococcal A, C, W-135 and Y conjugate vaccine in meningococcal disease (2 arms), sponsored by National Centre for Immunisation Research and Surveillance. Primary endpoint: Serogroup-specific meningococcal carriage after Hajj. Started Apr 2016; status: completed.
02
Drugs
meningococcal A, C, W-135 and Y conjugate vaccine
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on ACTRN12616001230448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616001230448.